Choice of the add-on therapy to metformin in type 2 diabetes patients in Romania

Abstrakt

The study by C. Serafinceanu et al., dealing with the reasons guiding physicians to select additional medication in type 2 diabetes mellitus when treatment with metformin only does not lead to sufficient metabolic control of the disease (HbA1c), has aroused our outmost interest.

Klíčová slova

• type 2 diabetes
• add-on therapy
• metformin
• metabolic control
• Romania
• HbAlc